Characterization of mice lacking the multidrug resistance protein MRP2 (ABCC2)

Xiao-Yan Chu1, John R Strauss, Michele A Mariano

  • 1Department of Drug Metabolism, Merck and Co., RY80, 126 E. Lincoln Ave., Rahway, NJ 07065, USA. xiaoyan_chu@merck.com

Insights

Mice lacking the multidrug resistance-associated protein 2 (Mrp2) show altered bilirubin transport and increased Mrp4 expression, offering a new model for studying Mrp2

Area of Science:

  • Biochemistry
  • Pharmacology
  • Genetics

Background:

  • Multidrug resistance protein 2 (Mrp2) is an ATP-binding cassette (ABC) transporter crucial for eliminating substances like bilirubin glucuronides from the liver.
  • Existing rat models exhibit hyperbilirubinemia and compensatory changes in other transporters, but their species-specificity is unclear.

Purpose of the Study:

  • To characterize Mrp2 knockout (Mrp2(-/-)) mice as a model system for studying Mrp2 function.
  • To investigate potential compensatory mechanisms in Mrp2(-/-) mice compared to rat models.

Main Methods:

  • Generation and characterization of Mrp2(-/-) mice.
  • Analysis of bilirubin and glutathione excretion, and Mrp2 substrate transport.
  • Quantitative comparison of gene and protein expression for 98 genes in liver, kidney, and intestine.

Main Results:

  • Mrp2(-/-) mice exhibited elevated serum bilirubin and glucuronides, reduced biliary excretion of these compounds and glutathione, and impaired dibromosulfophthalein transport.
  • Unlike rats, Mrp2(-/-) mice did not show Mrp3 induction but displayed significant increases in Mrp4 mRNA and protein in the liver and kidney.
  • No significant differences in major cytochrome P450 activities were observed between Mrp2(-/-) and wild-type mice.

Conclusions:

  • Mrp2(-/-) mice serve as a valuable new in vivo model for investigating the physiological and pharmacological roles of Mrp2.
  • The compensatory upregulation of Mrp4 in Mrp2(-/-) mice highlights distinct adaptive responses compared to rat models.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...